Puma Biotechnology, Inc. (PBYI) vs VectivBio Holding AG (VECT)
- Puma Biotechnology, Inc. PBYI 9.83 −6.56%
- VectivBio Holding AG VECT
Puma Biotechnology, Inc. and VectivBio Holding AG are both Biotechnology companies. Puma Biotechnology, Inc. and VectivBio Holding AG are of similar size ($545.5M and $543.0M). VectivBio Holding AG has negative trailing earnings, so its P/E is not meaningful; Puma Biotechnology, Inc. trades at 18.2×. Puma Biotechnology, Inc. has the higher net margin (11.6% vs 0.00%) and the higher return on invested capital (42.6% vs 0.00%). Across the 12 metrics below, Puma Biotechnology, Inc. leads on 10 and VectivBio Holding AG on 2.
Valuation
Profitability
| Metric | PBYI | VECT | Biotechnology median |
|---|---|---|---|
| Gross margin | 74.83% | — | 65.16% |
| Operating margin | 13.16% | — | 0.00% |
| Net margin | 11.55% | 0.00% | 0.00% |
| Free cash flow margin | 17.79% | 0.00% | 0.00% |
| Return on equity | 21.97% | (147.18%) | (56.36%) |
| Return on assets | 13.78% | (111.86%) | (48.04%) |
| Return on invested capital | 42.61% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack